INVO Bioscience Inc (INVO)
0.985
-0.02
(-1.50%)
USD |
NASDAQ |
May 17, 16:00
0.9836
0.00 (0.00%)
After-Hours: 20:00
INVO Bioscience Accounts Receivable (Quarterly): 0.1406M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.1406M |
September 30, 2023 | 0.1168M |
June 30, 2023 | 0.0749M |
March 31, 2023 | 0.0997M |
December 31, 2022 | 0.0771M |
September 30, 2022 | 0.0713M |
June 30, 2022 | 0.0565M |
March 31, 2022 | 0.0587M |
December 31, 2021 | 0.0505M |
September 30, 2021 | 0.0507M |
June 30, 2021 | 0.0479M |
March 31, 2021 | 0.5277M |
December 31, 2020 | 0.0217M |
September 30, 2020 | 0.0037M |
June 30, 2020 | 0.0712M |
March 31, 2020 | 0.0037M |
December 31, 2019 | 0.0076M |
Date | Value |
---|---|
September 30, 2019 | 0.027M |
June 30, 2019 | 0.2402M |
March 31, 2019 | 0.0747M |
December 31, 2018 | 0.2259M |
September 30, 2018 | 0.1871M |
June 30, 2018 | 0.1394M |
March 31, 2018 | 0.1109M |
December 31, 2017 | 0.0867M |
September 30, 2017 | 0.0602M |
June 30, 2017 | 0.043M |
March 31, 2017 | 0.0323M |
December 31, 2016 | 0.0028M |
September 30, 2016 | 0.0097M |
June 30, 2016 | 0.0182M |
March 31, 2016 | 0.0181M |
December 31, 2015 | 0.0013M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.0037M
Minimum
Mar 2020
0.5277M
Maximum
Mar 2021
0.092M
Average
0.0587M
Median
Mar 2022
Accounts Receivable (Quarterly) Benchmarks
Abbott Laboratories | 6.605B |
Perspective Therapeutics Inc | 0.999M |
Xtant Medical Holdings Inc | 21.48M |
Asensus Surgical Inc | 0.675M |
Catheter Precision Inc | 0.073M |